What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

 WHAT IS IDHIFA (Enasidenib)?

IDHIFA Medicine
IDHIFA Medicine
IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.

IDHIFA may cause serious side effects, including:

Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below.

  • ·         fever
  • ·         cough
  • ·         shortness of breath
  • ·         swelling of arms and legs
  • ·         fast weight gain (greater than 10 pounds within a week)
  • ·         bone pain

If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by mouth or given through a vein (intravenous) called corticosteroids and may monitor you in the hospital.

How Should I take IDHIFA?

Take IDHIFA Medicine 1 time a day at the same time each day. Swallow IDHIFA tablets whole with 8 ounces (one cup) of water. If you miss a dose of IDHIFA or vomit after taking a dose of IDHIFA, take the dose of IDHIFA as soon as possible on the same day.

Your healthcare provider should do blood tests to check your blood counts before you start IDHIFA treatment and at a minimum of every 2 weeks for at least the first 3 months during treatment to check for side effects

The Most Common Side Effects of IDHIFA include:

  • ·         nausea
  • ·         vomiting
  • ·         diarrhea
  • ·         jaundice
  • ·         decreased appetite

Tell your healthcare provider if you have any changes to the color of your skin or the whites of your eyes.

Location: New Delhi, Delhi, India

Comments

Post a Comment

Popular posts from this blog

Hunter Syndrome is Very Rare | Named Patient Program in India

Image
  Hunter Syndrome is an extremely uncommon, acquired hereditary problem brought about by an absent or breaking down compound. In Hunter disorder, the body needs more of the compound iduronate 2-sulfatase. This present compound's responsibility is to separate specific complex particles, and without enough of this protein, the atoms develop in unsafe sums.  The development of enormous measures of these unsafe substances in the long run causes long-lasting, moderate harm influencing appearance, mental turn of events, organ work and actual capacities. Hunter Syndrome is undeniably more normal in young men. The condition is one kind of a gathering of acquired metabolic issues called mucopolysaccharidoses (MPSs). Tracker condition is otherwise called MPS II. Import Elaprase (idursulfase) medicine under named patient program which is commonly use for hunter syndrome.  There's no remedy for Hunter disorder. Treatment includes overseeing side effects and difficulties. Side effects Syndr
Read more

Glyxambi (empagliflozin and linagliptin) Medicine - Uses, Precautions, Indications

Image
What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy
Read more